Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in PBYI held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ACORN CAPITAL ADVISORS, LLC | 4.1M | $33.5M | 0.0% | 8.117% | 9.14% |
| 2 | BlackRock, Inc. | 3.8M | $30.9M | +5.7% | 7.475% | 0.00% |
| 3 | AMERICAN CENTURY COMPANIES INC | 2.3M | $18.8M | +21.1% | 4.558% | 0.01% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 1.8M | $14.9M | -5.5% | 3.608% | 0.02% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $14.9M | +1.0% | 3.606% | 0.00% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.8M | $14.8M | +5.2% | 3.587% | 0.00% |
| 7 | DIMENSIONAL FUND ADVISORS LP | 1.5M | $12.3M | +5.7% | 2.982% | 0.00% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $10.9M | +31.7% | 2.631% | 0.00% |
| 9 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 1.1M | $9.1M | -1.3% | 2.208% | 0.04% |
| 10 | STATE STREET CORP | 952K | $7.7M | +3.8% | 1.871% | 0.00% |
| 11 | KENNEDY CAPITAL MANAGEMENT LLC | 873K | $7.1M | -1.8% | 1.716% | 0.13% |
| 12 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 792K | $6.4M | +2.1% | 1.555% | 0.11% |
| 13 | RITHOLTZ WEALTH MANAGEMENT | 750K | $6.1M | -3.2% | 1.473% | 0.05% |
| 14 | AQR CAPITAL MANAGEMENT LLC | 725K | $5.9M | -9.4% | 1.425% | 0.00% |
| 15 | GOLDMAN SACHS GROUP INC | 669K | $5.4M | -0.1% | 1.315% | 0.00% |
| 16 | NORTHERN TRUST CORP | 652K | $5.3M | +1.7% | 1.282% | 0.00% |
| 17 | Connor, Clark & Lunn Investment Management Ltd. | 643K | $5.2M | -17.9% | 1.263% | 0.01% |
| 18 | UBS Group AG | 637K | $5.2M | +19.2% | 1.251% | 0.00% |
| 19 | MILLENNIUM MANAGEMENT LLC | 602K | $4.9M | -59.2% | 1.183% | 0.00% |
| 20 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 532K | $4.3M | -1.1% | 1.046% | 0.00% |
| 21 | SEI INVESTMENTS CO | 419K | $3.4M | -17.6% | 0.823% | 0.00% |
| 22 | GLOBEFLEX CAPITAL L P | 383K | $3.1M | +9.5% | 0.752% | 0.40% |
| 23 | Bank of New York Mellon Corp | 361K | $2.9M | +3.7% | 0.709% | 0.00% |
| 24 | D. E. Shaw & Co., Inc. | 316K | $2.6M | -9.9% | 0.622% | 0.00% |
| 25 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 309K | $2.5M | +13.3% | 0.607% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in PBYI — a direct measure of their conviction.
Filings activity in PBYI during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new PBYI position in Q2 2026
Institutions that fully closed their PBYI position in Q2 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | +3.2% | 76.18% | +1.25 pp | $286M | +29% |
| Q1 2026 | 157 | +2.6% | 74.93% | +4.32 pp | $222M | +13% |
| Q4 2025 | 153 | +14% | 70.61% | +1.54 pp | $196M | +15% |
| Q3 2025 | 134 | +11% | 69.07% | +4.09 pp | $170M | +67% |
| Q2 2025 | 121 | +3.4% | 64.98% | +3.42 pp | $102M | +22% |
| Q1 2025 | 117 | +7.3% | 61.56% | +5.23 pp | $83M | +2.0% |
| Q4 2024 | 109 | +7.9% | 56.33% | 143.66 pp | $82M | 75% |
| Q3 2024 | 101 | — | 199.99% | — | $331M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Oncology Biotech peers.
Quick answers to the most common questions about buying PBYI stock.
Based on Q2 2026 13F filings, institutional ownership of Puma Biotechnology, Inc. stands at 76.2%, held across 162 reporting institutions.
ACORN CAPITAL ADVISORS, LLC is the largest reported institutional holder of PBYI, with approximately 4,131,299 shares worth $0.03B as of Q2 2026.
Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of PBYI, including RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC.
Our composite Smart Money Score for PBYI is 68 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
20 institutions opened new positions in PBYI during Q2 2026, while 14 fully exited. 122 added to existing positions and 17 trimmed.
PBYI institutional ownership rose by 1.25 percentage points quarter-over-quarter, with a net change of +5 holders.
The top 10 institutions account for 58.8% of all reported 13F value in PBYI, and the top 25 account for 83.4%.
Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), KYNB (26.9%), CNSY (4.8%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.